INFINITY PHARMACEUTICALS, INC. (INFI)

Healthcare: Diagnostic Substances

Brokerage Ratings
Closing price on 12/31/2009: $6.18
Filers holding this stock on 12/31/2009: 49
Aggregate shares on 12/31/2009: 9,831,607
Aggregate shares on 09/30/2009: 9,409,434
Percent change: 4.486699%
View insider trading info since Jan. 1 2008
Quarter 1: Quarter 2:
Brokerage Ratings on this stock:
Positive:
3
Neutral:
1
Negative:
1
Brokerage Date Issued Rating Price Target
ROTH CAPITAL 04/16/2009 SELL $4.00
RODMAN & RENSHAW 04/15/2009 MKT PERFORM
SUSQUEHANNA FINANCIAL 11/02/2008 POSITIVE
ROBERT W. BAIRD 08/05/2007 OUTPERFORM $16.00
JEFFERIES & CO 07/12/2007 BUY $15.00
Schedule 13d filings involving this stock
Filing Company Subject Company Date of Filing
View Schedule 13D BEACON CO INFINITY PHARMACEUTICALS, INC. 12/01/2008
View Amended Schedule 13D BEACON CO INFINITY PHARMACEUTICALS, INC. 01/16/2009
Non-derivative Insider Transactions
Transaction Date Owner Shares Purchased/Sold Edgar filing
08/27/2008
HOLTZMAN STEVEN H
 22,103 View Filing
11/24/2008
PERKINS ADELENE Q
 22,041 View Filing
12/16/2008
PERKINS ADELENE Q
 9,200 View Filing
01/07/2009
BEACON CO
 1,000,000 View Filing
01/07/2009
ROSEBAY MEDICAL CO L.P.
 1,000,000 View Filing